Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	2014
Period Ending	Jul '25 Jul 31, 2025	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016	Oct '15 Oct 31, 2015	Oct '14 Oct 31, 2014	2014
Market Capitalization	0	1	0	0	2	1	Upgrade
Market Cap Growth	7563.91%	164.77%	284.58%	-96.54%	130.13%	-	Upgrade
Enterprise Value	-	2	1	0	2	1	Upgrade
Last Close Price	0.00	0.70	0.70	0.70	700.28	420.17	Upgrade
PS Ratio	-	-	2695.49	22.30	88.03	23.00	Upgrade
PB Ratio	-0.01	-0.34	-0.27	-0.03	-1.19	-4.62	Upgrade
EV/Sales Ratio	-	-	5782.93	120.52	90.67	23.21	Upgrade
Debt / Equity Ratio	-0.34	-0.35	-0.74	-0.33	-0.14	-0.11	Upgrade
Asset Turnover	-	-	0.04	0.11	0.82	1.02	Upgrade
Quick Ratio	-	0	0.00	0.00	0.01	0.00	Upgrade
Current Ratio	0.00	0.00	0.00	0.00	0.03	0.02	Upgrade
Return on Assets (ROA)	-	-1506.15%	-7496.23%	-1583.54%	-2125.93%	-4875.35%	Upgrade
Earnings Yield	-222.51%	-29.40%	-142.22%	-2214.05%	-114.62%	-333.85%	Upgrade
FCF Yield	-132.74%	-17.93%	-82.20%	-846.88%	-24.52%	-23.20%	Upgrade
Buyback Yield / Dilution	-869781.24%	-23.75%	-1700.51%	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.